{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastro-Intestinal+Cancer&page=26", "query": { "condition": "Gastro-Intestinal Cancer", "page": 26 }, "page_size": 10 }, "pagination": { "page": 26, "page_size": 10, "total_count": 4291, "total_pages": 430, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastro-Intestinal+Cancer&page=27&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastro-Intestinal+Cancer&page=25&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-12T23:02:57.080Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06440005", "title": "A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer", "Advanced Cancer", "Locally Advanced Carcinoma", "Metastatic Solid Tumor", "Breast Cancer", "Prostate Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Liver Cancer", "Angiosarcoma", "Solid Tumor" ], "interventions": [ { "name": "AGX101", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Angiex, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2024-07-22", "completion_date": "2027-09-06", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 7, "location_summary": "Los Angeles, California • Sarasota, Florida • St Louis, Missouri + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06440005" }, { "nct_id": "NCT06750094", "title": "A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Colorectal Neoplasms" ], "interventions": [ { "name": "Amivantamab", "type": "BIOLOGICAL" }, { "name": "Cetuximab", "type": "BIOLOGICAL" }, { "name": "Bevacizumab", "type": "BIOLOGICAL" }, { "name": "5-fluorouracil", "type": "DRUG" }, { "name": "Leucovorin calcium/Levoleucovorin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 700, "start_date": "2024-12-12", "completion_date": "2029-04-13", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 71, "location_summary": "Chandler, Arizona • Gilbert, Arizona • Prescott, Arizona + 60 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Prescott", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06750094" }, { "nct_id": "NCT00017056", "title": "BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Esophageal Cancer", "Gastric Cancer" ], "interventions": [ { "name": "ixabepilone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2001-02", "completion_date": "2002-01", "has_results": false, "last_update_posted_date": "2013-06-18", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00017056" }, { "nct_id": "NCT00896454", "title": "Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Hypercalcemia of Malignancy", "Colon Cancer", "Endocrine Cancer", "Head and Neck Cancer", "Kidney Cancer", "Lung Cancer", "Lymphoma", "Metastatic Cancer", "Multiple Myeloma", "Parathyroid Neoplasms", "Renal Cancer", "Thyroid Cancer", "Hodgkin's Lymphoma", "Non-Hodgkin's Lymphoma", "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "denosumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2009-11-16", "completion_date": "2013-08-21", "has_results": true, "last_update_posted_date": "2018-10-17", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 12, "location_summary": "Encinitas, California • New Haven, Connecticut • Salisbury, Maryland + 9 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Salisbury", "state": "Maryland" }, { "city": "Dearborn", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00896454" }, { "nct_id": "NCT04890054", "title": "Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Carcinoma" ], "interventions": [ { "name": "Fecal Immunochemical Test", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Patient Navigation", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5696, "start_date": "2021-05-14", "completion_date": "2024-07-01", "has_results": true, "last_update_posted_date": "2025-08-19", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04890054" }, { "nct_id": "NCT02008656", "title": "Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rectal Cancer" ], "interventions": [ { "name": "Oxaliplatin (OXAL)", "type": "DRUG" }, { "name": "5-Fluorouracil (5-FU)", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Capecitabine (Xeloda®)", "type": "DRUG" }, { "name": "intensity modulated radiotherapy (IMRT)", "type": "RADIATION" }, { "name": "Quality of Life Questionnaires", "type": "BEHAVIORAL" }, { "name": "DRE-Endoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 358, "start_date": "2013-11", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 26, "location_summary": "Irvine, California • Orange, California • San Francisco, California + 22 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02008656" }, { "nct_id": "NCT02530983", "title": "Mayo Clinic Upper Digestive Disease Survey", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Esophageal Neoplasms", "Cancer of Esophagus", "Cancer of the Esophagus", "Esophageal Cancer", "Esophagus Cancer", "Neoplasm, Esophageal", "Esophagectomy", "Abnormalities, Digestive System", "Digestive System Abnormalities" ], "interventions": [ { "name": "Mayo Clinic Upper Digestive Disease Survey on Paper", "type": "OTHER" }, { "name": "Upper Digestive Disease (UDD Monitor) App", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2015-08-15", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-03-30", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02530983" }, { "nct_id": "NCT00118105", "title": "S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer", "Metastatic Cancer" ], "interventions": [ { "name": "bevacizumab", "type": "BIOLOGICAL" }, { "name": "capecitabine", "type": "DRUG" }, { "name": "oxaliplatin", "type": "DRUG" }, { "name": "conventional surgery", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2006-11", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2013-01-03", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 46, "location_summary": "Los Angeles, California • Aurora, Illinois • Joliet, Illinois + 25 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Illinois" }, { "city": "Joliet", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" }, { "city": "Urbana", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00118105" }, { "nct_id": "NCT03694522", "title": "A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastric Cancer" ], "interventions": [ { "name": "Bemarituzumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Modified FOLFOX6", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Five Prime Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2018-09-14", "completion_date": "2022-05-13", "has_results": true, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 29, "location_summary": "Tucson, Arizona • Greenbrae, California • Sacramento, California + 23 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Greenbrae", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03694522" }, { "nct_id": "NCT01286883", "title": "Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2011-02", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2018-08-20", "last_synced_at": "2026-11-12T23:02:57.080Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01286883" } ] }